DK1824515T3 - Behandling af dermatitis med dehydroepiandrosteron-glukokortikoidkombinationer - Google Patents

Behandling af dermatitis med dehydroepiandrosteron-glukokortikoidkombinationer

Info

Publication number
DK1824515T3
DK1824515T3 DK05807524T DK05807524T DK1824515T3 DK 1824515 T3 DK1824515 T3 DK 1824515T3 DK 05807524 T DK05807524 T DK 05807524T DK 05807524 T DK05807524 T DK 05807524T DK 1824515 T3 DK1824515 T3 DK 1824515T3
Authority
DK
Denmark
Prior art keywords
glucocorticoid
dehydroepiandrosterone
dermatitis
combinations
treatment
Prior art date
Application number
DK05807524T
Other languages
Danish (da)
English (en)
Inventor
Thomas D Geracioti Jr
Original Assignee
Rxdino Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rxdino Llc filed Critical Rxdino Llc
Application granted granted Critical
Publication of DK1824515T3 publication Critical patent/DK1824515T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
DK05807524T 2004-09-24 2005-09-08 Behandling af dermatitis med dehydroepiandrosteron-glukokortikoidkombinationer DK1824515T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61271704P 2004-09-24 2004-09-24
US11/108,032 US8084444B2 (en) 2004-09-24 2005-04-15 Treatment of dermatitis with dehydroepiandrosterone-glucocorticoid combinations
PCT/US2005/031850 WO2006036484A2 (fr) 2004-09-24 2005-09-08 Traitement de dermatite au moyen de combinaisons de deshydroepiandrosterone-glucocorticoide

Publications (1)

Publication Number Publication Date
DK1824515T3 true DK1824515T3 (da) 2009-06-29

Family

ID=36100080

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05807524T DK1824515T3 (da) 2004-09-24 2005-09-08 Behandling af dermatitis med dehydroepiandrosteron-glukokortikoidkombinationer

Country Status (9)

Country Link
US (1) US8084444B2 (fr)
EP (1) EP1824515B1 (fr)
AT (1) ATE427122T1 (fr)
CA (1) CA2581364A1 (fr)
DE (1) DE602005013690D1 (fr)
DK (1) DK1824515T3 (fr)
ES (1) ES2321857T3 (fr)
PL (1) PL1824515T3 (fr)
WO (1) WO2006036484A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2539952T3 (es) 2008-06-30 2015-07-07 Schwartz, Arthur Formulaciones esteroideas tópicas
US20100086581A1 (en) * 2008-10-07 2010-04-08 Ernest Bove Method for purpura reduction and prevention
WO2012129305A1 (fr) * 2011-03-23 2012-09-27 Pop Test Cortisol Llc Polythérapie
WO2017091681A1 (fr) 2015-11-24 2017-06-01 Aclaris Therapeutics, Inc. Inhibiteurs de kinase sélectifs

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496556A (en) * 1982-08-16 1985-01-29 Norman Orentreich Topical applications for preventing dry skin
WO1994008589A1 (fr) * 1992-10-09 1994-04-28 The Board Of Trustees Of The Leland Stanford Junior University Traitement du lupus erythemateux systemique a la deshydroepiandrosterone
WO1995015746A1 (fr) * 1993-12-10 1995-06-15 The School Of Pharmacy Systemes d'administration de liposomes
JPH07258091A (ja) * 1994-03-17 1995-10-09 Kyowa Hakko Kogyo Co Ltd アトピー性皮膚炎治療剤
GB9612990D0 (en) * 1996-06-20 1996-08-21 Stanford Rock Ltd Compositions and methods for the treatment of chronic infections
US5861391A (en) * 1997-01-29 1999-01-19 Research Development Foundation Use of dehydroepiandrosterone to treat primary adrenal insufficiency and Addison's disease
US6479058B1 (en) * 1999-09-02 2002-11-12 Mccadden Michael E. Composition for the topical treatment of poison ivy and other forms of contact dermatitis
US6552010B1 (en) 1999-11-12 2003-04-22 Genelabs Technologies, Inc. Treatment of SLE with dehydroepiandrosterone
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
FR2848844B1 (fr) * 2002-12-18 2005-05-06 Oreal Utilisation d'un alkylether d'hydroxystilbene pour le traitement des peaux seches

Also Published As

Publication number Publication date
WO2006036484A3 (fr) 2006-06-01
PL1824515T3 (pl) 2009-08-31
US8084444B2 (en) 2011-12-27
DE602005013690D1 (de) 2009-05-14
EP1824515B1 (fr) 2009-04-01
ES2321857T3 (es) 2009-06-12
US20060069071A1 (en) 2006-03-30
WO2006036484A2 (fr) 2006-04-06
ATE427122T1 (de) 2009-04-15
EP1824515A2 (fr) 2007-08-29
CA2581364A1 (fr) 2006-04-06

Similar Documents

Publication Publication Date Title
MY161021A (en) Controlled release corticosteroid and methods for the treatment of otic disorders
ATE404206T1 (de) Orale suspension mit meloxicam
WO2013078422A3 (fr) Préparations et thérapies de substitution pour hormonothérapie naturelle combinée
ATE448777T1 (de) Mittel für die transdermale verabreichung von nikotin
WO2009072007A3 (fr) Porteurs, formulations, procédés pour formuler des agents actifs instables pour application externe et utilisations associées
MX2020013533A (es) Formulaciones y terapias de reemplazo de combinacion de hormonas naturales.
EP1827332A4 (fr) Dispositifs donneurs de monoxyde d'azote topiques et leurs methodes d'utilisation a des fins therapeutiques
ATE516797T1 (de) Topische polyaphron-zusammensetzung mit vitamin d und kortikosteroid
DE602005016551D1 (de) Stabilisierte supergesättigte feste lösungen von steroidalen arzneimitteln
WO2012100097A3 (fr) Compositions topiques de minocycline et leurs procédés d'utilisation
IL184145A0 (en) Transdermal, therapeutic system with activatable oversaturation and controlled permeation promotion
DE602004027120D1 (de) Orale und/oder topische Zubereitungen
NO20081790L (no) Topiske formuleringer
GB2445674B (en) Compositions for the topical treatment of eczema, psoriasis and the like
NO20064053L (no) Androgen reseptormodulatorer
DK1824515T3 (da) Behandling af dermatitis med dehydroepiandrosteron-glukokortikoidkombinationer
WO2007137224A3 (fr) Méthode de traitement
MX2007002917A (es) Todo-trans-retinol: todo-trans-13, 14-dihidrorretinol saturasa y metodos de uso de la misma.
MX2010005119A (es) Corticosteroides para tratar la diarrea inducida por la epotilona o los derivados de epotilona.
CY1112973T1 (el) Περαιτερω κρυσταλλικες μορφες ροσταφουροξινης
DK1732921T3 (da) Thiomidderivater som progesteronreceptormodulatorer
GB2411573B (en) Undergarment with linking and bracing device
WO2005034858A8 (fr) Compositions et methodes pour traiter une douleur musculaire ou une atrophie musculaire
DK1635843T3 (da) Terapi, der omfatter dienogest for hormonerstatning og depression
任秀珍 et al. A Study of Stereotypes in Intercultural Communication